U.S. markets closed
  • S&P Futures

    3,939.75
    -32.00 (-0.81%)
     
  • Dow Futures

    31,703.00
    -136.00 (-0.43%)
     
  • Nasdaq Futures

    11,871.25
    -164.00 (-1.36%)
     
  • Russell 2000 Futures

    1,782.70
    -9.10 (-0.51%)
     
  • Crude Oil

    109.49
    -0.80 (-0.73%)
     
  • Gold

    1,848.40
    +0.60 (+0.03%)
     
  • Silver

    21.66
    -0.07 (-0.31%)
     
  • EUR/USD

    1.0668
    -0.0029 (-0.27%)
     
  • 10-Yr Bond

    2.8590
    +0.0720 (+2.58%)
     
  • Vix

    28.48
    -0.95 (-3.23%)
     
  • GBP/USD

    1.2555
    -0.0033 (-0.26%)
     
  • USD/JPY

    127.8480
    -0.0400 (-0.03%)
     
  • BTC-USD

    29,215.07
    -855.28 (-2.84%)
     
  • CMC Crypto 200

    654.70
    -20.18 (-2.99%)
     
  • FTSE 100

    7,513.44
    +123.46 (+1.67%)
     
  • Nikkei 225

    26,888.43
    -113.09 (-0.42%)
     

Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SILVER SPRING, Md., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference.

A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the investor section of the Company’s website at www.Aziyo.com

About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com